Abstract PO1-15-05: Gene Expression Signature As a Predictor of Pathological Complete Response to Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab Treatment in Locally Advanced HER2-positive Breast Cancer
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要